Industries > Pharma > Contract Research Organisations (CROs) Market Report 2022-2032
Back to Pharma Reports
Contract Research Organisations (CROs) Market Report 2022-2032

Contract Research Organisations (CROs) Market Report 2022-2032

Forecasts by Services (Preclinical, Clinical (Phase I, Phase II, Phase III, Phase IV), Laboratory Services, Consulting Services, Data Management Services), by Company Size (Large Pharma & Biotech Companies, Mid-sized Pharma & Biotech Companies, Small Pharma & Biotech Companies), by Drug Type (Small Molecules, Large Molecules), by Therapeutic Area (Oncology, CNS, Cardiology, Infectious, Metabolic, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis

PUBLISHED: 12 August 2022
PAGES: 305
PRODUCT CODE: PHA1183
SUBMARKET: Contract Services

WOOCS 2.2.1
DOWNLOAD FREE SAMPLE
SKU: PHA1183 Categories: , Tags: , , , , , ,

The Contract Research Organizations (CROs) Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Patent Expiry and Increasing Demand for Generic Drugs Projected to Drive Overall CROs Growth
One of the main factors fuelling the demand for generics is the pressure to lower the rising healthcare expenses. The market entry of various less expensive generic substitutes was made possible by patent expiration. Since generic manufacturing firms contract with CDMOs for over 80% of their manufacturing, patent expiration is a positive indication of a booming market. Some of the well-known medications whose patents ran out in 2021 include Lucentis from Roche, Adasuve from Galen, Performist from Mylan, Northera from Lundbeck, and Narcan from Emergent BioSolutions.

Supply Chain Disruptions Likely to Hamper Market
The pharmaceutical sector is susceptible to supply chain disruptions caused by natural disasters in a particular location. High inventory levels alone are insufficient to protect against supply chain shocks since disruptions are becoming more frequent, for instance, the COVID-19 pandemic two years ago and the recent monkeypox outbreak. Anticipatory planning is necessary for managing supply chain interruptions, and several of the large CROs are already highly proficient at foreseeing and resolving shortages. Smaller CROs, however, are more likely to face supply chain disruptions.

The larger CROs have the financial capacity to keep large inventory in case of future financial constraints. The smaller CROs lack the infrastructure and resources necessary to manage supply chains and prevent shortages. Despite difficulties including managing sponsors, workforce scarcity, and market consolidation, the demand for outsourced R&D services will continue to support the CRO business.

What Questions Should You Ask before Buying a Market Research Report?
• How is the Contract Research Organizations (CROs) market evolving?
• What is driving and restraining the Contract Research Organizations (CROs) market?
• How will each Contract Research Organizations (CROs) submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2032?
• How will the market shares for each Contract Research Organizations (CROs) submarket develop from 2022 to 2032?
• What will be the main driver for the overall market from 2022 to 2032?
• Will leading Contract Research Organizations (CROs) markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032?
• Who are the leading players and what are their prospects over the forecast period?
• What are the Contract Research Organizations (CROs) projects for these leading companies?
• How will the industry evolve during the period between 2020 and 2032? What are the implications of Contract Research Organizations (CROs) projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the Contract Research Organizations (CROs) market?
• Where is the Contract Research Organizations (CROs) market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the Contract Research Organizations (CROs) market today, and over the next 10 years:
• Our 305-page report provides 116 tables and 180 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the Contract Research Organizations (CROs) market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

The report delivers exclusive COVID-19 variations and economic data specific to your market.

To access the data contained in this document, please email contactus@visiongain.com

Forecasts to 2032 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising Contract Research Organizations (CROs) prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Services Outlook
• Preclinical
• Clinical
– Phase I
– Phase II
– Phase III
– Phase IV
• Laboratory Services
• Consulting Services
• Data Management Services

Company Size Outlook
• Large Pharma & Biotech Companies
• Mid-sized Pharma & Biotech Companies
• Small Pharma & Biotech Companies

Drug Type Outlook
• Small Molecules
• Large Molecules

Therapeutic Area Outlook
• Oncology
• CNS
• Cardiology
• Infectious
• Metabolic
• Others

CTA

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 20 leading national markets:

North America
• U.S.
• Canada

Europe
• Germany
• UK
• France
• Italy
• Spain
• Rest of Europe

Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific

Latin America
• Brazil
• Mexio
• Rest of Latin America

MEA
• GCC
• South Africa
• Rest of MEA

Contract Research Organisations (CROs) Market Report 2022-2032
Need industry data? Please contact us today.

The report also includes profiles and for some of the leading companies in the Contract Research Organizations (CROs) Market, 2022 to 2032, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
• Charles River Laboratories
• Clinipace
• CMIC HOLDING Co., LTD.
• EPS Corporation
• ICON plc
• IQVIA HOLDINGS INC.
• Labcorp Drug Development
• MedPace
• Parexel
• PPD (Thermofisher Scientific Inc.)
• Syneos Health
• Worldwide Clinical Trials
• Wuxi AppTec

Overall world revenue for Contract Research Organizations (CROs) Market, 2022 to 2032 in terms of value the market will surpass US$62 billion in 2022, our work calculates. We predict strong revenue growth through to 2032.

Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Contract Research Organizations (CROs) Market, 2022 to 2032 report help you?
In summary, our 300+ page report provides you with the following knowledge:

• Revenue forecasts to 2032 for Contract Research Organizations (CROs) Market, 2022 to 2032 Market, with forecasts for services, company size, drug type, and therapeutic area each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.

• Revenue forecasts to 2032 for four regional and 13 key national markets – See forecasts for the Contract Research Organizations (CROs) Market, 2022 to 2032 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market – including company profiles for 13 of the major companies involved in the Contract Research Organizations (CROs) Market, 2022 to 2032.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Contract Research Organizations (CROs) Market, 2022 to 2032, market-leading companies. You will find data, trends and predictions.

To access the data contained in this document please email contactus@visiongain.com

Buy our report today Contract Research Organisations (CROs) Market Report 2022-2032: Forecasts by Services (Preclinical, Clinical (Phase I, Phase II, Phase III, Phase IV), Laboratory Services, Consulting Services, Data Management Services), by Company Size (Large Pharma & Biotech Companies, Mid-sized Pharma & Biotech Companies, Small Pharma & Biotech Companies), by Drug Type (Small Molecules, Large Molecules), by Therapeutic Area (Oncology, CNS, Cardiology, Infectious, Metabolic, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Contract Research Organisations (CROs) Market Report 2022-2032

    Related reports

    Download sample pages

    Complete the form below to download your free sample pages for Contract Research Organisations (CROs) Market Report 2022-2032

      Connect with us

      Visiongain Pharma

      Visiongain Pharma

      Visiongain Pharma

      Latest Pharma news

      Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034

      The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.

      18 April 2024

      READ
      Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034

      The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.

      17 April 2024

      READ
      Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034

      The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.

      12 April 2024

      READ
      Visiongain Publishes Inflammatory Bowel Diseases (IBD) Drugs Market Report 2024-2034

      The global Inflammatory Bowel Diseases (IBD) Drugs market was valued at US$27.53 billion in 2023 and is projected to grow at a CAGR of 6.2% during the forecast period 2024-2034.

      11 April 2024

      READ